Search
for
Sort by
Research 121–150 of 501
- Tinea Capitis: An Overview with Emphasis on Management
- No evidence for the immunocompetence handicap hypothesis in male humans
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Acquired Zinc Deficiency
- Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
- Animal models for the study of fetal tissue repair
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Management of congenital ichthyoses: European guidelines of care, part two
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Skin Manifestations in Primary Immunodeficient Children
- Adverse Reactions to Oral Retinoids An Update
- Efficacy of tofacitinib in treatment of alopecia universalis in two patients
- Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
- Delayed-Onset Hemolytic Anemia in Patients with Travel-Associated Severe Malaria Treated with Artesunate, France, 2011–2013
- TOXIC EPIDERMAL NECROLYSIS
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Adverse Cutaneous Reactions to Antidepressants
- MOUSE MODELS FOR THE STUDY OF HUMAN HAIR LOSS
- Severe Physical Complications among Survivors of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
- Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations
- Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
- Hypersensitivity Reactions to Anticoagulant Drugs
- Skin manifestations among<i>GATA2</i>-deficient patients
- Reversible Alopecia Universalis During Treatment with PEG-Interferon and Ribavirin for Chronic Hepatitis C
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Psychodermatology
- Recurrence of Pemphigus Vulgaris Associated With Interleukin 2 Therapy
- Nutrition and the deleterious side effects of nutritional supplements
- INTERFERONS IN DERMATOLOGY